NCT06817551
Comparison of Outcomes of Management of Bowel Obstruction Pilot Study
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentUniversity of WashingtonInvestigator-initiated
~10 participants
Updated 2025-03-12 on ClinicalTrials.gov
What's tested:DexamethasoneSupportive Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Resolution of aSBO
Measured over 30 days
Conditions
Where it's being run
1 sites across 1 statesWashington1
Study leadership
- David Flum, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Washington
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults ≥18 years of age recruited from UWMC
Patients presenting to surgical services through the Emergency Department, diagnosis of SBO, consulted by surgeon, and an urgent or emergency operation is deemed not necessary by surgeon.
Diagnosis of aSBO is established by;
Ability to provide written or electronic informed consent in English and answer teach-back questions
Exclusion
Signs and symptoms of peritonitis with emergency operation planned
Planned urgent operation within the next 12 hours
Allergy to dexamethasone
Surgery within prior 6 weeks
Unable or unwilling to return or be contacted for and/or complete research surveys
Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening
Individuals with latent infections who have an increased risk of infection.
What this trial measures
- Resolution of aSBO30 days
The primary outcome is the resolution of aSBO, defined as the absence of obstruction symptoms, in patients receiving dexamethasone + supportive care compared to those receiving supportive care alone.